Selenium research in vascular disease.
Abstract
The trace element selenium is crucial for cellular defense against oxidative stress and inflammatory reactions. Balanced selenium levels are important for the vascular system, whereas dysregulation can damage vascular reactivity. Reports have also supported the strong relationship between oxidative stress and vascular inflammation, which are induced by either the overproduction of reactive oxygen species (ROS) or the lack of antioxidant defense proteins. The damage of vascular smooth muscle and endothelium layer are frequently linked to vascular disorders such as hypertension, hypercholesterolemia, and atherosclerosis. Vascular diseases can result in life-threatening serious cardiovascular complications, such as blood clots, heart attack, and stroke. Selenium levels are crucial for preventing vascular damage; however, either low or extremely high amounts of selenium intake may contribute to the pathophysiology of vascular disorders. Selenoproteins are proteins such as glutathione peroxidase containing selenium in the form of the 21st amino acid, selenocysteine. Selenoproteins have the capacity to protect vascular smooth muscle and endothelium by lowering harmful ROS, which allows them to regulate normal vascular functions including vasoreactivity. The current chapter’s goal was to carry out a thorough evaluation of the literature on the connection between selenium and vascular disorders.
Keywords
- selenium
- selenoproteins
- vascular system
- vascular disease
- hypertension
1. Introduction
Selenium is a cofactor of enzymes that are responsible for antioxidant protection in the body. It is abundant in the environment at varying levels and plays an important role in the regulation of inflammatory processes in the body [1]. Adequate bioavailable levels of selenium in the organism are functionally important for many aspects of human biology, including the cardiovascular system, central nervous system, male reproductive biology, endocrine system, muscle function, and immunity [2]. Selenium is an essential component of selenoproteins, which play an important role in a variety of biological functions including antioxidant defense, thyroid hormone formation, DNA synthesis, fertility, and reproduction [3]. Many selenoproteins have been identified in the organism, including glutathione peroxidases (GPXs), thioredoxin reductase (TrxR), iodothyronine deiodinase, selenoprotein P, and selenoprotein W [4]. GPXs of the selenoprotein family are antioxidants that play an important role in oxidative stress and vascular tissue damage [5]. When the oxidative-antioxidant balance function is disrupted as a result of oxidative stress, several pathogenic processes can occur in vascular system. Oxidative stress and the formation of reactive oxygen species (ROS) contribute to the progression of tissue injury by activating the inflammatory response via the release of proinflammatory cytokines and the accumulation of inflammatory cells in tissues [6]. Endothelial dysfunction is important in the development of vascular diseases, and selenium reduces endothelial damage and prevents disruption of endothelial-dependent relaxation [7]. While a lack of selenium can lead to a variety of diseases, an excess of selenium can be toxic and result in the selenosis condition [8]. Low or excessive selenium consumption has been linked to different vascular diseases such as hypertension, hypercholesterolemia, and atherosclerosis [9]. The fundamental pharmacological, physiological, and pathophysiological properties of selenium in vascular disease are presented in this chapter.
2. The relationship between selenium and vascular diseases
Vascular smooth muscle (VSM) tone in the arterial vessels determines peripheral vascular resistance and blood pressure. Endothelial cells regulate VSM tone and subsequently blood flow by producing and releasing relaxants such as nitric oxide and contractile substances such as endothelin. The defective function of VSM and endothelial layer are commonly associated with impaired vascular responses [10]. The coexistence of dyslipidemia and oxidative stress is a major risk factor for the development of vascular diseases such as atherosclerosis and hypertension [11]. VSM and endothelial cells function properly and maintain an appropriate oxidant/antioxidant balance when selenium and selenoproteins are present in the proper amounts [12]. A sufficient concentration of selenium-dependent GPXs is required to maintain an active endogenous antioxidant system, which prevents vascular diseases caused by hypertension, hypercholesterolemia, and atherosclerosis [13]. Overall, the GPX family is one of the best-studied selenoprotein families in cardiovascular biology. There are five different types of GPX isoforms, with GPx-3 being the only one found in the extracellular space [14]. GPx-3 deficiency causes a prothrombotic state and vascular dysfunction, which promotes platelet-dependent arterial thrombosis [9]. The link between low selenium intake and cardiovascular pathologies is due to increased oxidative stress and its consequences in the development of non-infectious vascular diseases [15]. Decreased amount of selenium in the body is associated with an increase in adhesion molecules and a decrease in the expression of selenoproteins despite endothelial cell integrity and function [16]. A potentially harmful relationship was discovered between high selenium levels and carotid wall thickening, despite a long-term vascular protective effect between arterial stiffness and blood pressure in people with normal selenium levels [17]. All of this points to a significant relationship between selenium and the vascular system. Table 1 summarizes studies demonstrating the effect of selenium on vascular diseases.
Disease | Species | Method | Conclusion | References |
---|---|---|---|---|
Hypertension | Human | Selenium deficiency | Higher risk in pregnancy-induced hypertension | [18] |
Hypertension | Human | Higher selenium levels | Lower risk in ischemic stroke | [19] |
Hypertension | Human | Higher selenium levels | Selenium protects vascular function | [20] |
Hypertension | Human | Higher selenium levels | Higher prevalence of hypertension | [21] |
Hypertension | Rat | Selenium deficiency | Increase in AT1 receptors and blood pressure | [22] |
Hypertension | Rat | Higher selenium levels | Increase in systolic blood pressure | [23] |
Dyslipidemia | Human | Selenium deficiency | Low HDL levels, high LDL levels | [24] |
Hyperlipidemia | Human | Selenium deficiency | Selenium may prevent hyperlipidemia | [25] |
Dyslipidemia and atherosclerosis | Rabbit | 0.5% dietary cholesterol-induced dyslipidemic rabbits | Co-supplementation of vitamin K2 and selenium improved metabolic profile and atherosclerosis | [26] |
Hyperlipidemia | Mice | Selenium nanoparticles | Selenium reduces hyperlipidemia and vascular injury | [27] |
Hyperlipidemia | Mice | High fat diet-induced dyslipidemia | Selenium-rich | [28] |
Endothelial dysfunction | Rat | Homocysteine-induced endothelial dysfunction and apoptosis | Selenium protects against homocysteine-induced dysfunction and apoptosis of endothelial cells. | [7] |
Endothelial dysfunction | Rat | Streptozotocin-induced diabetic aorta | Selenium improved vascular responses and endothelial dysfunction | [29] |
2.1 Hypertension
Because of its high prevalence and associated risks of cardiovascular and kidney disease, hypertension is a major public health issue worldwide [30]. Endothelial dysfunction, inflammation, hypertrophy, apoptosis, cell migration, fibrosis, and angiogenesis have all been linked to vascular remodeling in hypertension [31].
2.2 Hypercholesterolemia and atherosclerosis
Hyperlipidemia, caused by hypercholesterolemia and/or hypertriglyceridemia, is a critical condition that plays a significant role in the pathogenesis of atherosclerosis [37]. Apoptotic VSM cells, which are found in advanced atherosclerosis, cause plaque instability and rupture, which results in thrombosis and the clinical symptoms of a heart attack or stroke [38]. Selenoproteins can destroy cholesterol that has accumulated in the vascular lumen. Inadequate plasma selenium levels can lead to vascular disease by lowering selenoprotein levels [39]. Optimal Se uptake prevents atherosclerosis by reducing oxidative stress, inflammation, endothelial dysfunction, vascular cell apoptosis, and vascular calcification [40]. Selenium supplementation increases GPX1, GPX4, and TRXR1 expression and activity in vascular endothelial or smooth muscle cells. As a result, it prevents oxidative stress, cell damage, and apoptosis caused by oxidized low-density lipoprotein (LDL), a cytotoxic hydroxylated cholesterol derivative found in human blood, cells, tissues, and atherosclerotic plaques [41]. The selenoenzyme GPX uses GSH as an electron donor to neutralize hydroperoxide and protects against arsenic-induced atherosclerosis in a mouse model [42]. In healthy young subjects, a negative relationship was found between serum triglycerides and sialic acid, an inflammation marker, and dietary selenium intake [43]. Experimental studies have shown that selenium is used in combination with other substances and improves hyperlipidemia more strongly. It was reported that concomitant administration of vitamin K2 and selenium improved metabolic function, markers of cardiovascular health, and atherosclerosis in dyslipidemic rabbits [26].
3. Conclusions
These findings suggest that adequate selenium intake may contribute to preventing the development of hypertension, hyperlipidemia, and atherosclerosis by reducing oxidative stress and inflammation associated with vascular diseases. Furthermore, the findings emphasize the importance of consuming or supplementing with an adequate amount of selenium to optimize vascular system function. Selenium appears to have both a protective and a therapeutic role in the vascular dysfunction, and more research on the effect of selenium on the vascular system is required. As a result of the recent studies, it is understood that people living in low selenium-containing regions should be protected from vascular damage by taking selenium supplements. Selenium, which regulates blood pressure and reduces atherosclerosis caused by hyperlipidemia, could be used as a potential pharmacological agent in the prevention of vascular diseases in the near future.
References
- 1.
Kieliszek M. Selenium. Advances in Food and Nutrition Research. 2021; 96 :417-429 - 2.
Avery JC, Hoffmann PR. Selenium, selenoproteins, and immunity. Nutrients. 2018; 10 (9):1203 - 3.
Mehdi Y, Hornick JL, Istasse L, Dufrasne I. Selenium in the environment, metabolism and involvement in body functions. Molecules. 2013; 18 (3):3292-3311 - 4.
Sur Ü, Erkekoğlu P, Koçer-Gümüşel B. Selenoproteinler ve Hashimoto Tiroiditi. Journal of Pharmaceutical Sciences. 2020; 45 (1):45-64 - 5.
Brigelius-Flohé R, Maiorino M. Glutathione peroxidases. Biochimica et Biophysica Acta - General Subjects. 2013; 1830 (5):3289-3303 - 6.
Doğan MF, Kaya K, Demirel HH, Şahin Y, Çiftçi O. The effect of vitamin C supplementation on favipiravir-induced oxidative stress and proinflammatory damage in livers and kidneys of rats and proinflammatory damage in livers and kidneys of rats. Immunopharmacology and Immunotoxicology. 2023:1-6 - 7.
Ren H et al. Selenium inhibits homocysteine-induced endothelial dysfunction and apoptosis via activation of AKT. Cellular Physiology and Biochemistry. 2016; 38 (3):871-882 - 8.
Hariharan S, Dharmaraj S. Selenium and selenoproteins: it’s role in regulation of inflammation. Inflammopharmacology. 2020; 28 (3):667-695 - 9.
Shimada BK, Alfulaij N, Seale LA. The impact of selenium deficiency on cardiovascular function. International Journal of Molecular Sciences. 2021; 22 (19):10713 - 10.
Dogan MF, Yildiz O, Arslan SO, Ulusoy KG. Potassium channels in vascular smooth muscle: A pathophysiological and pharmacological perspective. Fundamental & Clinical Pharmacology. 2019; 33 (5):504-523 - 11.
Holvoet P. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verhandelingen - Koninklijke Academie voor Geneeskunde van België. 2008; 70 (3):193-219 - 12.
Gać P et al. The importance of selenium and zinc deficiency in cardiovascular disorders. Environmental Toxicology and Pharmacology. 2021; 82 :103553 - 13.
Jenkins DJA et al. Selenium, antioxidants, cardiovascular disease, and all-cause mortality: A systematic review and meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition. 2020; 112 (6):1642-1652 - 14.
Jin RC et al. Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo. Circulation. 2011; 123 (18):1963-1973 - 15.
Benstoem C et al. Selenium and its supplementation in cardiovascular disease—What do we know? Nutrients. 2015; 7 (5):3094-3118 - 16.
Lopes Junior E, Leite HP, Konstantyner T. Selenium and selenoproteins: From endothelial cytoprotection to clinical outcomes. Translational Research. 2019; 208 :85-104 - 17.
Swart R, Schutte AE, van Rooyen JM, Mels CMC. Selenium and large artery structure and function: A 10-year prospective study. European Journal of Nutrition. 2019; 58 (8):3313-3323 - 18.
Lewandowska M, Sajdak S, Lubiński J. Serum selenium level in early healthy pregnancy as a risk marker of pregnancy induced hypertension. Nutrients. 2019; 11 (5):1028 - 19.
Wang Z et al. Plasma selenium and the risk of first stroke in adults with hypertension: A secondary analysis of the China stroke primary prevention trial. The American Journal of Clinical Nutrition. 2022; 115 (1):222-231 - 20.
Hu XF, Eccles KM, Chan HM. High selenium exposure lowers the odds ratios for hypertension, stroke, and myocardial infarction associated with mercury exposure among Inuit in Canada. Environment International. 2017; 102 :200-206 - 21.
Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium concentrations and hypertension in the US population. Circulation. Cardiovascular Quality and Outcomes. 2009; 2 (4):369-376 - 22.
Lei L et al. Selenium deficiency causes hypertension by increasing renal AT1 receptor expression via GPx1/H2O2/NF-κB pathway. Free Radical Biology & Medicine. 2023; 200 :59-72 - 23.
Grotto D, Carneiro MFH, de Castro MM, Garcia SC, Junior FB. Long-term excessive selenium supplementation induces hypertension in rats. Biological Trace Element Research. 2018; 182 (1):70-77 - 24.
Arnaud J, Akbaraly TN, Hininger-Favier I, Berr C, Roussel AM. Fibrates but not statins increase plasma selenium in dyslipidemic aged patients - the EVA study. Journal of Trace Elements in Medicine and Biology. 2009; 23 (1):21-28 - 25.
Lee O, Moon J, Chung Y. The relationship between serum selenium levels and lipid profiles in adult women. Journal of Nutritional Science and Vitaminology (Tokyo). 2003; 49 (6):397-404 - 26.
Atteia HH. Co-supplementation of vitamin K2 and selenium synergistically improves metabolic status and reduces cardiovascular risk markers in Dyslipidemic rabbits. Biological Trace Element Research. 2023:1-15 - 27.
Guo L, Xiao J, Liu H, Liu H. Selenium nanoparticles alleviate hyperlipidemia and vascular injury in ApoE-deficient mice by regulating cholesterol metabolism and reducing oxidative stress. Metallomics. 2020; 12 (2):204-217 - 28.
Yu M et al. Anti-hyperlipidemia and gut microbiota community regulation effects of selenium-rich cordyceps militaris polysaccharides on the high-fat diet-fed mice model. Food. 2021; 10 (10):2252 - 29.
Ozturk Z, Gurpinar T, Vural K, Boyacioglu S, Korkmaz M, Var A. Effects of selenium on endothelial dysfunction and metabolic profile in low dose streptozotocin induced diabetic rats fed a high fat diet. Biotechnic & Histochemistry. 2015; 90 (7):506-515 - 30.
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005; 365 (9455):217-223 - 31.
Sinha N, Dabla P. Oxidative stress and antioxidants in hypertension–A current review. Current Hypertension Reviews. 2015; 11 (2):132-142 - 32.
Nawrot TS et al. Blood pressure and blood selenium: A cross-sectional and longitudinal population study. European Heart Journal. 2007; 28 (5):628-633 - 33.
Arnaud J, Akbaraly NT, Hininger I, Roussel AM, Berr C. Factors associated with longitudinal plasma selenium decline in the elderly: The EVA study. The Journal of Nutritional Biochemistry. 2007; 18 (7):482-487 - 34.
Xie C et al. Regional difference in the association between the trajectory of selenium intake and hypertension: A 20-year cohort study. Nutrients. 2021; 13 (5):1501 - 35.
Kuruppu D, Hendrie HC, Yang L, Gao S. Selenium levels and hypertension: A systematic review of the literature. Public Health Nutrition. 2014; 17 (6):1342-1352 - 36.
Zachariah M, Maamoun H, Milano L, Rayman MP, Meira LB, Agouni A. Endoplasmic reticulum stress and oxidative stress drive endothelial dysfunction induced by high selenium. Journal of Cellular Physiology. 2021; 236 (6):4348-4359 - 37.
Tietge UJF. Hyperlipidemia and cardiovascular disease: Inflammation, dyslipidemia, and atherosclerosis. Current Opinion in Lipidology. 2014; 25 (1):94-95 - 38.
Kockx MM, Herman AG. Apoptosis in atherosclerosis: Beneficial or detrimental? Cardiovascular Research. 2000; 45 (3):736-746 - 39.
Kielczykowska M, Kocot J, Pazdzior M, Musik I. Selenium - a fascinating antioxidant of protective properties. Advances in Clinical and Experimental Medicine. 2018; 27 (2):245-255 - 40.
Liu H, Xu H, Huang K. Selenium in the prevention of atherosclerosis and its underlying mechanisms. Metallomics. 2017; 9 (1):21-37 - 41.
Bellinger FP, Raman AV, Reeves MA, Berry MJ. Regulation and function of selenoproteins in human disease. Biochemical Journal. 2009; 422 (1):11-22 - 42.
Krohn RM et al. High-selenium lentil diet protects against arsenic-induced atherosclerosis in a mouse model. The Journal of Nutritional Biochemistry. 2016; 27 :9-15 - 43.
Zulet MÁ, Puchau B, Hermsdorff HHM, Navarro C, Martínez JA. Dietary selenium intake is negatively associated with serum sialic acid and metabolic syndrome features in healthy young adults. Nutrition Research. 2009; 29 (1):41-48